# China NMPA Drug Inspection - Xianhe Traditional Chinese Medicine Processing Plant, Qiqihar City, Heilongjiang Province - safflower

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/xianhe-traditional-chinese-medicine-processing-plant-qiqihar-city-heilongjiang-province/65d64f07-a2d1-4568-b44b-fe0ebf8b53b1/
Source feed: China

> China NMPA drug inspection for Xianhe Traditional Chinese Medicine Processing Plant, Qiqihar City, Heilongjiang Province published January 12, 2017. Drug: safflower. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement No. 5 of 2017 from the State Administration for Market Regulation on the Results of Special Sampling Inspections of Chinese Medicinal Herbs and Prepared Slices
- Company Name: Xianhe Traditional Chinese Medicine Processing Plant, Qiqihar City, Heilongjiang Province
- Publication Date: 2017-01-12
- Drug Name: safflower
- Inspection Finding: Tartrazine, Golden Orange II, and Sunset Yellow were detected, indicating dyeing issues. Additionally, some batches of products failed to meet standard requirements regarding appearance, identification, impurities, or content determination.
- Action Taken: We have taken timely and lawful measures to control the products, including sealing and seizing, suspending production and sales, and requiring companies to voluntarily recall their products. We have also filed cases against the relevant companies and units for investigation and punishment.

Company: https://www.globalkeysolutions.net/companies/xianhe-traditional-chinese-medicine-processing-plant-qiqihar-city-heilongjiang-province/ebfb511a-1ddd-437f-8b2d-940200161f2b/